XML 60 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
 6 Months Ended
Sep. 27, 2014
Sep. 28, 2013
Cash Flows from Operating Activities:    
Net income $ 3,839 $ 8,674
Non-cash items:    
Depreciation and amortization 41,625 38,256
Amortization of financing costs 572 815
Stock compensation expense 6,938 6,416
Purchase of in-process R&D 0 (3,569)
Loss on sale of property, plant and equipment 364 265
Unrealized loss from hedging activities 554 2,266
Contingent consideration expense 459 310
Asset write-down 474 1,675
Change in operating assets and liabilities:    
Decrease in accounts receivable, net 10,145 8,689
Increase in inventories (13,185) (19,338)
Increase in prepaid income taxes (2,028) (1,459)
(Decrease)/Increase in other assets and other liabilities (8,160) 5,067
Tax benefit of exercise of stock options 854 1,338
Increase/(Decrease) in accounts payable and accrued expenses 2,529 (13,781)
Net cash provided by operating activities 44,980 42,762
Cash Flows from Investing Activities:    
Capital expenditures on property, plant and equipment (70,872) (28,202)
Proceeds from sale of property, plant and equipment 377 642
Acquisition of Hemerus 0 (23,124)
Other acquisitions and investments 0 8,707
Net cash used in investing activities (70,495) (59,391)
Cash Flows from Financing Activities:    
Payments on long-term real estate mortgage (513) (472)
Net increase in short-term loans 786 4,240
Repayment of term loan borrowings (8,531) (20,000)
Proceeds from employee stock purchase plan 2,530 2,666
Proceeds from exercise of stock options 4,042 8,117
Excess tax benefit on exercise of stock options 0 1,581
Share repurchases (33,770) 0
Net cash used in financing activities (35,456) (3,868)
Effect of exchange rates on cash and cash equivalents (1,527) 525
Net Decrease in Cash and Cash Equivalents (62,498) (19,972)
Cash and Cash Equivalents at Beginning of Period 192,469 179,120
Cash and Cash Equivalents at End of Period 129,971 159,148
Non-cash Investing and Financing Activities:    
Transfers from inventory to fixed assets for placement of Haemonetics equipment 4,026 6,034
Supplemental Disclosures of Cash Flow Information:    
Interest paid 4,180 4,722
Income taxes paid $ 8,351 $ 3,666